Sort
15,842 grants matching “pancreatic cancer”
Magnetic Resonance Fingerprinting of Tumor Vascular Perfusion and Acidosis
$653,560Christopher A Flask · Case Western Reserve University · R01 · FY2025 · CA
ECM geometrical and mechanical properties modulate RTK signaling
$653,481Jay T. Groves · University Of California Berkeley · U01 · FY2015 · CA
Causes and Consequences of Adenosine Signaling in Pancreatic Cancer
$653,452Timothy R Donahue · University Of California Los Angeles · R01 · FY2024 · CA
Project 1: Systematic discovery of cell-intrinsic mechanisms of cancer drug resistance
$653,390Scott R Manalis · Massachusetts Institute Of Technology · U54 · FY2017 · CA
PROSPECTIVE STUDY OF PANCREATIC CANCER PATHOGENESIS
$653,041Brigham And Women'S Hospital · R01 · FY2003 · CA
Image guided intervention system for pancreatic cystic lesions
$652,932Nicusor Iftimia · Physical Sciences, Inc · R44 · FY2009 · CA
Project 1: Systematic discovery of cell-intrinsic mechanisms of cancer drug resistance
$652,398Scott R Manalis · Massachusetts Institute Of Technology · U54 · FY2021 · CA
Real-time MRI-guided adaptive radiotherapy of unresectable pancreatic cancer
$652,055Ricardo Otazo · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Image-guided ultrasound therapy and drug delivery in pancreatic cancer
$652,017Katherine W Ferrara · Stanford University · R01 · FY2018 · CA
Regulation of metastasis by alpha V integrin and Src
$651,648David A Cheresh · University Of California, San Diego · R01 · FY2009 · CA
A single-arm phase II study to evaluate the safety and efficacy of combination systematic chemotherapy and multiple rounds of endoscopic ultrasound-guided radiofrequency ablation in pancreatic cancer
$651,173Nirav Thosani · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · CA
Controlling Tumor Immune Escape in Pancreatic Cancer using a Dual T Cell Product Strategy
$650,671Juan Fernando Vera · Marker Therapeutics, Inc. · R44 · FY2024 · CA
Multifunctional Nanoparticles in Diagnosis and Therapy
$650,658Paras N. Prasad · State University Of New York At Buffalo · R01 · FY2006 · CA
Project 2-Identifying and exploiting metabolic vulnerabilities in PDAC
$650,399Nabeel Bardeesy · University Of Tx Md Anderson Can Ctr · P01 · FY2024 · CA
Peptide-based targeted molecular imaging for early detection in pancreatic cancer
$650,375Julie L Sutcliffe · University Of California At Davis · U01 · FY2017 · CA
Seromic Mucin Signature for the Early Diagnosis of Pancreatic Cancer
$650,357Wade M Junker · Sanguine Diagnostics And Therapeutics · R44 · FY2018 · CA
Seromic Mucin Signature for the Early Diagnosis of Pancreatic Cancer
$650,357Joshua James Souchek · Sanguine Diagnostics And Therapeutics · R44 · FY2019 · CA
Image-guided ultrasound therapy and drug delivery in pancreatic cancer
$650,148Katherine W Ferrara · Stanford University · R01 · FY2020 · CA
Detecting cancer early with targeted nano-probes
$650,000University Of California San Francisco · R01 · FY2005 · CA
TAS:: 75 0850 ::TAS RECOVERY ACT - ACTNOW CLINICAL TRIAL 8418 UNDER
$650,000Everett E Vokes · University Of Chicago · N01 · FY2009 · CA
Uncovering Oncogenotype-specific Vulnerabilities in Lung cancer
$649,778Jiyeon Kim · Yale University · R37 · FY2025 · CA
Understanding Pancreatic Cancer Immune Microenvironment and Treatment Response through Integrating in vivo Imaging with Immunophenotyping
$649,473Jun Yan · University Of Louisville · R01 · FY2024 · CA
Understanding Pancreatic Cancer Immune Microenvironment and Treatment Response through Integrating in vivo Imaging with Immunophenotyping
$649,473Jun Yan · University Of Louisville · R01 · FY2025 · CA
Imaging Acidosis and Immune Therapy in PDAC
$649,329Shari Pilon-Thomas · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA
Project 2: Splicing Dysregulation in Cancer
$648,960Adrian R Krainer · Cold Spring Harbor Laboratory · P01 · FY2023 · CA